Mining Microbial Gold : Unlocking the Hidden Potential of Streptomyces in Antibiotic Discovery

 

With antibiotic resistance rising at an alarming rate, the need for new antibiotics is urgent, and Streptomyces, which produces approximately two‑thirds of all known antibiotics, remains our most powerful natural source for discovering them. Despite producing many antibiotics through secondary metabolism, there are many cryptic secondary metabolite pathways that are not activated under laboratory conditions. 

The Streptomyces undergoes complex developmental stages; spore dormancy where the cells remain metabolically inactive in stressful conditions, in the presence of water, trehalose, and cations they undergo germination eventually leading to MI (primary mycelium), programmed cell-death that releases signals like N-acetylglucosamine accelerating development and secondary metabolism, MII (secondary mycelium) where the antibiotics are produced after differentiation of MII, followed by aerial mycelium and sporulation. In liquid medium, there is no sporulation but they still undergo MI to PCD to MII transitions.

After three decades of research only two new antibiotics classes have reached clinics. Upon sequencing the genome it was revealed that there were 20-50 biosynthetic gene clusters per strain. Researchers have come up with various strategies for discovering new compounds. 

Unusual and extreme habitats like marine, deserts, mountains, glaciers yield new species and metabolites. By isolating Streptomyces from such underexplored niches, scientists have uncovered strains with chemical profiles completely different from those found in conventional environments. Another promising strategy focuses on Streptomyces that live in a symbiotic relationship with plants, insects and fungi that often involve chemical communication or defence, which produces highly specialized compounds. Additionally, countless potential antibiotic producers have remained inaccessible as they are unculturable in laboratory conditions until iChip, an innovative tool was used to isolate these species in their native conditions. 

While exploring new environments, symbiotic relationships, and unculturable microorganisms has opened up vast new biological space, researchers have also developed laboratory‑based strategies to activate silent pathways and boost secondary metabolite production in known Streptomyces strains. Media optimization and stress induction can trigger secondary metabolism. Random mutagenesis using chemical, UV, transposon mutagenesis can create high-yield producing strains. Additionally, engineering mutations in ribosomal proteins using ribosomal engineering can activate cryptic pathways. Small molecules called elicitors can act like cues that trigger differentiation and activate defense pathways that may or may not produce antibiotics.

While unselective methods are broad and work based on hoping to activate any hidden pathway or discover something entirely new, selective methods are more targeted. These strategies focus on boosting the production of specific known molecules by directly manipulating the genetic or regulatory machinery of Streptomyces.  By overexpressing positive regulators or deleting repressors in the antibiotic biosynthetic pathway researchers can increase the yield of desired compounds. Heterologous expression can also be used to transfer entire biosynthetic gene clusters from one strain to another tractable host that is well studied. 

Additionally, using genome mining, a bioinformatic tool to sequence the genome and scan for biosynthetic gene clusters or combinatorial biosynthesis to tailor antibiotic structures, improve potency and generate chemical diversity can be used to unlock silent biosynthetic pathways and expand the range of antibiotics available for discovery. 

Together, these strategies signal a shift in how we search for new drugs. Instead of relying on chance discoveries, we are learning to coax, engineer, and explore our way into the microbial dark matter that has been waiting beneath the surface. The challenge is immense, but so is the promise. With the right tools and a renewed scientific imagination, Streptomyces may once again lead us into a new golden age of antibiotic discovery, one that the world urgently needs.

REFERENCE

Manteca, Á., & Yagüe, P. (2019). to Activate Cryptic Secondary Metabolite Pathways. Antimicrobials, Antibiotic Resistance, Antibiofilm Strategies and Activity Methods, 119. 

IMAGE REFERENCE

https://upload.wikimedia.org/wikipedia/commons/d/d9/Streptomyces_griseus_color_enhanced_scanning_electron_micrograph..jpg